Yhb Investment Advisors, Inc. Amgen Inc Transaction History

Yhb Investment Advisors, Inc.

$1.2 Billion
Q4 2024

A detailed history of Yhb Investment Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Yhb Investment Advisors, Inc. holds 43,514 shares of AMGN stock, worth $13.4 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

43,514

Previous 42,913 1.4%

Holding current value

$13.4 Million

Previous $13.8 Million 17.97%

% of portfolio

0.95%

Previous 1.17%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$258.78 - $328.31 $155,526 - $197,314	601 Added 1.4%	43,514 $11.3 Million
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $22,275 - $24,291	-72 Reduced 0.17%	42,913 $13.8 Million
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $76,985 - $93,557	-293 Reduced 0.68%	42,985 $13.4 Million
Q1 2024 Aug 14, 2024	BUY	$268.87 - $324.56 $78,778 - $95,096	293 Added 0.68%	43,278 $12.3 Million
Q1 2024 Apr 26, 2024	BUY	$268.87 - $324.56 $95,986 - $115,867	357 Added 0.83%	43,278 $12.3 Million
Q4 2023 Jan 29, 2024	SELL	$255.7 - $288.46 $917,707 - $1.04 Million	-3,589 Reduced 7.72%	42,921 $12.4 Million
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $11,588 - $14,387	53 Added 0.11%	46,510 $12.5 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $67,495 - $79,811	-315 Reduced 0.67%	46,457 $10.3 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $72,027 - $87,788	319 Added 0.69%	46,772 $11.3 Million
Q4 2022 Jan 12, 2023	SELL	$229.03 - $291.01 $153,221 - $194,685	-669 Reduced 1.42%	46,453 $0
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $61,277 - $69,109	273 Added 0.58%	47,122 $10.6 Million
Q2 2022 Jul 14, 2022	SELL	$230.71 - $256.74 $91,822 - $102,182	-398 Reduced 0.84%	46,849 $11.4 Million
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $325,615 - $360,216	-1,485 Reduced 3.05%	47,247 $11.4 Million
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $110,975 - $127,000	558 Added 1.16%	48,732 $11 Million
Q3 2021 Oct 28, 2021	BUY	$212.27 - $248.7 $158,353 - $185,530	746 Added 1.57%	48,174 $10.2 Million
Q2 2021 Jul 15, 2021	BUY	$233.58 - $259.14 $10,744 - $11,920	46 Added 0.1%	47,428 $11.6 Million
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $61,690 - $71,890	278 Added 0.59%	47,382 $12.1 Million
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $38,732 - $46,122	179 Added 0.38%	47,104 $10.8 Million
Q3 2020 Nov 02, 2020	SELL	$234.65 - $260.95 $1.79 Million - $1.99 Million	-7,643 Reduced 14.01%	46,925 $11.9 Million
Q2 2020 Jul 20, 2020	BUY	$197.81 - $242.74 $150,929 - $185,210	763 Added 1.42%	54,568 $12.9 Million
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $449,586 - $596,273	2,467 Added 4.81%	53,805 $10.9 Million
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $18,921 - $24,320	-100 Reduced 0.19%	51,338 $12.4 Million
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $327,152 - $391,996	1,879 Added 3.79%	51,438 $9.95 Million
Q2 2019 Jul 15, 2019	BUY	$166.7 - $195.41 $97,186 - $113,924	583 Added 1.19%	49,559 $9.13 Million
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $70,539 - $79,513	390 Added 0.8%	48,976 $9.3 Million
Q4 2018 Jan 11, 2019	BUY	$178.4 - $208.25 $740,360 - $864,237	4,150 Added 9.34%	48,586 $9.46 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $61,701 - $69,560	-333 Reduced 0.74%	44,436 $9.21 Million
Q2 2018 Jul 09, 2018	SELL	$166.05 - $186.51 $13,450 - $15,107	-81 Reduced 0.18%	44,769 $8.26 Million
Q1 2018 Apr 16, 2018	BUY	$169.43 - $198.0 $135,205 - $158,004	798 Added 1.81%	44,850 $7.65 Million
Q4 2017 Jan 16, 2018	BUY	$168.79 - $188.59 $67,853 - $75,813	402 Added 0.92%	44,052 $7.66 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $7.3 Million - $8.34 Million	43,650	43,650 $8.14 Million

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.

Account

Yhb Investment Advisors, Inc. Amgen Inc Transaction History